![Shui On Leung](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Shui On Leung
Directeur Général chez
SINOMAB BIOSCIENCE LIMITED
Fortune : 21 M $ au 31/05/2026
Profil
Shui On Leung is the founder of Sinomab Bioscience Ltd. since 2001, holding the title of Chairman & Chief Executive Officer.
Current job includes serving as Director at Hong Kong Genome Institute.
Former jobs include Associate Director-Molecular Biology Department at Immunomedics, Inc. from 1991 to 2000, Managing Director at The Hong Kong Institute of Biotechnology Ltd. from 2000 to 2003, and Director at Novelmab Ltd. from 2011 to 2018.
Education includes a doctorate from the University of Oxford conferred in 1989, an undergraduate degree from The Chinese University of Hong Kong conferred in 1984, a graduate degree from The Chinese University of Hong Kong conferred in 1986, and an MBA from The Chinese University of Hong Kong conferred in 2006.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/08/2025 | 129 729 200 ( 9,36% ) | 21 M $ | 31/05/2026 |
Postes actifs de Shui On Leung
| Sociétés | Poste | Début |
|---|---|---|
| SINOMAB BIOSCIENCE LIMITED | Directeur Général | 01/01/2003 |
Hong Kong Genome Institute | Directeur/Membre du Conseil | - |
Anciens postes connus de Shui On Leung
| Sociétés | Poste | Fin |
|---|---|---|
Novelmab Ltd. | Directeur/Membre du Conseil | 01/07/2018 |
The Hong Kong Institute of Biotechnology Ltd. | Directeur Général | 01/08/2003 |
| IMMUNOMEDICS, INC. | Corporate Officer/Principal | 01/07/2000 |
Formation de Shui On Leung
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
96
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Chinese University of Hong Kong
 The Chinese University of Hong Kong Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Hong Kong Institute of Biotechnology Ltd. | |
Sinomab Bioscience Ltd.
 Sinomab Bioscience Ltd. BiotechnologyHealth Technology Manufactures and distributes antibodies | Health Technology |
Novelmab Ltd. | |
Hong Kong Genome Institute |
